Buybacks and M&A Accelerate as HK Small-Caps Navigate Earnings PressureGlobal Report·Aug 18 at 04:43 AM01681-2.50%02172-1.21%
The Algorithm's Misfits: What 10 Random HK Stocks Say About the MarketGlobal Report·Aug 6 at 04:15 AM00003-0.80%00066-0.24%
From currency hedging to AI pivots: Hong Kong equities point to shifting cross-border flowsGlobal Report·Jul 28 at 04:13 AM01681-2.50%06988-4.00%
The Hong Kong Market's Island of Misfit Toys: Who to Watch and Who to IgnoreGlobal Report·Jul 24 at 04:13 AM02553+7.11%01681-2.50%
Beyond the Tech Giants: The Micro-Transitions Reshaping Hong Kong's Equities in 2026Global Report·Jul 18 at 04:13 AM03288-0.12%02498-9.41%
China Everbright Sticks to Its Buy Rating for Consun Pharmaceutical Group Ltd. (C1P)Tip Ranks·Jul 5 at 06:45 PM01681-2.50%
Consun Pharma files HKEX next-day disclosure return reporting share buybackPUBT·Jun 30 at 07:18 AM01681-2.50%
Consun Pharma files HKEX next-day disclosure return after share repurchase at HKD 12.55 average pricePUBT·Jun 26 at 05:01 AM01681-2.50%
Consun Pharma files HKEX next-day disclosure return after share buyback at HKD 12.83PUBT·Jun 26 at 02:23 AM01681-2.50%
Consun Pharma files HKEX next-day disclosure return on share repurchase at HKD 12.79 eachPUBT·Jun 22 at 07:03 AM01681-2.50%
Consun Pharma files HKEX next-day disclosure return, reports share repurchase for treasury sharesPUBT·Jun 18 at 07:35 AM01681-2.50%
Consun Pharma files HKEX next-day disclosure return on share repurchase at HKD 13.22 eachPUBT·Jun 17 at 06:52 AM01681-2.50%
